Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19 Immunobiology: Lessons Learned, New Questions Arise. | Front Immunol | 2021 | 34512643 | PubTator, text mining | PubMed |
| Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. | Bioorg Med Chem | 2021 | 34509862 | PubTator, text mining | PubMed |
| SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3. | Cytokine | 2021 | 34509038 | PubTator, text mining | PubMed |
| Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations. | Molecules | 2021 | 34500548 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Recent advances in management of COVID-19: A review. | Biomed Pharmacother | 2021 | 34488083 | PubTator, text mining | PubMed |
| Know your enemy and know yourself - the case of SARS-CoV-2 host factors. | Curr Opin Virol | 2021 | 34488003 | PubTator, text mining | PubMed |
| SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases. | Biochim Biophys Acta Mol Basis Dis | 2021 | 34481867 | PubTator, text mining | PubMed |
| An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. | J Integr Med | 2021 | 34479848 | PubTator, text mining | PubMed |
| Ethacridine inhibits SARS-CoV-2 by inactivating viral particles. | PLoS Pathog | 2021 | 34478458 | PubTator, text mining | PubMed |
| Identification of a novel avian coronavirus infectious bronchitis virus variant with three-nucleotide-deletion in nucleocapsid gene in China. | J Vet Med Sci | 2021 | 34470981 | PubTator, text mining | PubMed |
| SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. | Future Microbiol | 2021 | 34468163 | PubTator, text mining | PubMed |
| Predicting hosts based on early SARS-CoV-2 samples and analyzing the 2020 pandemic. | Sci Rep | 2021 | 34465838 | PubTator, text mining | PubMed |
| Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets. | Curr Opin Virol | 2021 | 34464844 | PubTator, text mining | PubMed |
| An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. | Comput Struct Biotechnol J | 2021 | 34457214 | PubTator, text mining | PubMed |
| Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. | Proc Natl Acad Sci U S A | 2021 | 34452991 | PubTator, text mining | PubMed |
| Diversity of Coronaviruses in Wild Representatives of the Aves Class in Poland. | Viruses | 2021 | 34452362 | PubTator, text mining | PubMed |
| Rotavirus A Genome Segments Show Distinct Segregation and Codon Usage Patterns. | Viruses | 2021 | 34452326 | PubTator, text mining | PubMed |
| Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development-A Perspective Review. | Vaccines (Basel) | 2021 | 34451937 | PubTator, text mining | PubMed |
| Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. | Signal Transduct Target Ther | 2021 | 34446699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=74